Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Protein kinase CK2 is a constitutively active enzyme that promotes cell survival: strategies to identify CK2 substrates and manipulate its activity in mammalian cells.

Turowec JP, Duncan JS, French AC, Gyenis L, St Denis NA, Vilk G, Litchfield DW.

Methods Enzymol. 2010;484:471-93. doi: 10.1016/B978-0-12-381298-8.00023-X.

PMID:
21036246
2.

Assessment of CK2 constitutive activity in cancer cells.

Ruzzene M, Di Maira G, Tosoni K, Pinna LA.

Methods Enzymol. 2010;484:495-514. doi: 10.1016/B978-0-12-381298-8.00024-1.

PMID:
21036247
3.

Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells.

Vilk G, Weber JE, Turowec JP, Duncan JS, Wu C, Derksen DR, Zien P, Sarno S, Donella-Deana A, Lajoie G, Pinna LA, Li SS, Litchfield DW.

Cell Signal. 2008 Nov;20(11):1942-51. doi: 10.1016/j.cellsig.2008.07.002. Epub 2008 Jul 6.

PMID:
18662771
4.

Casein Kinase II: an attractive target for anti-cancer drug design.

Hanif IM, Hanif IM, Shazib MA, Ahmad KA, Pervaiz S.

Int J Biochem Cell Biol. 2010 Oct;42(10):1602-5. doi: 10.1016/j.biocel.2010.06.010. Epub 2010 Jun 15. Review.

PMID:
20558317
5.

Order or chaos? An evaluation of the regulation of protein kinase CK2.

Olsten ME, Litchfield DW.

Biochem Cell Biol. 2004 Dec;82(6):681-93. Review.

PMID:
15674436
6.
7.

Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2.

Gyenis L, Duncan JS, Turowec JP, Bretner M, Litchfield DW.

J Proteome Res. 2011 Nov 4;10(11):4887-901. doi: 10.1021/pr2008994. Epub 2011 Oct 13.

8.

An unbiased evaluation of CK2 inhibitors by chemoproteomics: characterization of inhibitor effects on CK2 and identification of novel inhibitor targets.

Duncan JS, Gyenis L, Lenehan J, Bretner M, Graves LM, Haystead TA, Litchfield DW.

Mol Cell Proteomics. 2008 Jun;7(6):1077-88. doi: 10.1074/mcp.M700559-MCP200. Epub 2008 Feb 7.

9.
10.

In vitro and in vivo assays of protein kinase CK2 activity.

Prudent R, Sautel CF, Moucadel V, Laudet B, Filhol O, Cochet C.

Methods Enzymol. 2010;485:597-610. doi: 10.1016/B978-0-12-381296-4.00031-2.

PMID:
21050938
11.

Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells.

Salvi M, Xu D, Chen Y, Cabrelle A, Sarno S, Pinna LA.

Biochem Biophys Res Commun. 2009 Sep 25;387(3):606-10. doi: 10.1016/j.bbrc.2009.07.067. Epub 2009 Jul 17.

PMID:
19616514
12.

Inducible expression of protein kinase CK2 in mammalian cells. Evidence for functional specialization of CK2 isoforms.

Vilk G, Saulnier RB, St Pierre R, Litchfield DW.

J Biol Chem. 1999 May 14;274(20):14406-14.

13.

Protein kinase CK2 in health and disease: From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival.

St-Denis NA, Litchfield DW.

Cell Mol Life Sci. 2009 Jun;66(11-12):1817-29. doi: 10.1007/s00018-009-9150-2. Review.

PMID:
19387552
14.

Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.

Di Maira G, Brustolon F, Bertacchini J, Tosoni K, Marmiroli S, Pinna LA, Ruzzene M.

Oncogene. 2007 Oct 18;26(48):6915-26. Epub 2007 May 7.

PMID:
17486073
15.

Cell cycle and activation of CK2.

Homma MK, Homma Y.

Mol Cell Biochem. 2008 Sep;316(1-2):49-55. doi: 10.1007/s11010-008-9823-4. Epub 2008 Jul 23.

PMID:
18649047
16.

Regulation of caspase pathways by protein kinase CK2: identification of proteins with overlapping CK2 and caspase consensus motifs.

Turowec JP, Duncan JS, Gloor GB, Litchfield DW.

Mol Cell Biochem. 2011 Oct;356(1-2):159-67. doi: 10.1007/s11010-011-0972-5. Epub 2011 Jul 13.

PMID:
21750976
17.

Protein kinase CK2 interacts with the splicing factor hPrp3p.

Lehnert S, Götz C, Kartarius S, Schäfer B, Montenarh M.

Oncogene. 2008 Apr 10;27(17):2390-400. Epub 2007 Nov 19.

PMID:
18026141
18.

Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter.

Roosbeek S, Peelman F, Verhee A, Labeur C, Caster H, Lensink MF, Cirulli C, Grooten J, Cochet C, Vandekerckhove J, Amoresano A, Chimini G, Tavernier J, Rosseneu M.

J Biol Chem. 2004 Sep 3;279(36):37779-88. Epub 2004 Jun 24.

19.

Protein kinase CK2: a newcomer in the 'druggable kinome'.

Pagano MA, Cesaro L, Meggio F, Pinna LA.

Biochem Soc Trans. 2006 Dec;34(Pt 6):1303-6.

PMID:
17073807
20.

The antiapoptotic protein ICBP90 is a target for protein kinase 2.

Bronner C, Trotzier MA, Filhol O, Cochet C, Rochette-Egly C, Schöller-Guinard M, Klein JP, Mousli M.

Ann N Y Acad Sci. 2004 Dec;1030:355-60.

PMID:
15659817

Supplemental Content

Support Center